FDA grants IDE to SpinaFX for study of Triojection
June 10, 2026
The planned trial is expected to include 300 participants across two treatment arms.
The planned trial is expected to include 300 participants across two treatment arms.
Designed for spinal fusion surgery, Lux is designed to increase the chances of procedural success and provide greater flexibility once implants are fitted.
The procedure is comparable to hip and knee replacement surgeries, where a prosthetic implant is used to replace damaged joint surfaces
Published today in Cell, the team applied machine learning to blood plasma protein data from more than 48,000 UK Biobank participants, using matched cancer registry records to identify those who later developed lung cancer.
Irvine, CA-based OrthAlign has announced FDA 510(k) clearance for the Lantern ASC system, a handheld orthopedic navigation solution designed for ambulatory surgery centers. The system pairs a reusable navigation unit with a procedural Smart Pack Kit to deliver accurate, real-time navigation for total knee, partial knee, and gap balancing procedures in both primary and revision cases.
Researchers at Tampere University, Finland, have developed a groundbreaking 3D-printed ceramic implant material that closely mimics real human bone.
With FDA clearance in hand, Rivanna highlighted that it will accelerate the development of further AI capabilities for the Accuro XV system.
FORT LAUDERDALE, Fla., May 7, 2026 /PRNewswire/ — Spinal Resources, Inc., a developer of advanced spinal stabilization technologies, today announced the issuance of U.S. Patent No. 12,611,231, “Spinal Rod and Systems Thereof”.
ADDISON, Texas, May 5, 2026 /PRNewswire/ — FX Shoulder Solutions, Inc. has received FDA 510(k) clearance for the FX V135® Easytech Shoulder System, the next generation of stemless shoulder arthroplasty implants that provides surgeons with an anatomic stemless versus a modular stemmed-reverse option. This design enables surgeons to begin with a stemless approach and, when clinically appropriate, transition intraoperatively to a short stem solution without changing or adding another system.
GRAND RAPIDS, Mich., April 30, 2026 /PRNewswire/ — Capitan Orthopedics, Inc. (https://capitanortho.com/) announced today that it has been granted Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its SupraSpacerTM implant.